High analytical concordance between a novel companion diagnostic assay and an IUO assay for BRAF V600E/V600K detection in melanoma

被引：0
|
作者：
O'Donnell, L. [1 ]
Sweet, W. [1 ]
Lu, X. [1 ]
Meynier, F. [2 ]
Derome, A. [3 ]
Ganee, L. [4 ]
Poyet-Gelas, F. [3 ]
Martin, A. [5 ]
Casey, M. [6 ]
Kertesz, N. [7 ]
机构：
[1] BioMerieux Inc, Clin Affairs, Durham, NC USA
[2] BioMerieux Inc, BioMath, Grenoble, France
[3] BioMerieux Inc, V&V, Grenoble, France
[4] BioMerieux Inc, Prod Design & Dev, Grenoble, France
[5] GSK, Oncol, Collegeville, PA USA
[6] GSK, Stat, Collegeville, PA USA
[7] Response Genet Inc, Pharmaceut Liaison Manager, Los Angeles, CA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MC13-0053
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [31] A role for immunohistochemical detection of BRAF V600E in metastatic melanoma?
    Lade-Keller, J.
    Kristensen, L. S.
    Riber-Hansen, R.
    Guldberg, P.
    Hansen, L. L.
    Steiniche, T.
    Hager, H.
    APMIS, 2013, 121 : 7 - 7
  • [32] Distinct gene expression, mutational profile and clinical outcomes of V600E and V600K/R BRAF-mutant metastatic melanoma (MM).
    Da Silva, Ines Esteves Domingues Pires
    Wang, Kevin Y. X.
    Wilmott, James S.
    Hoist, Jeffrey
    Park, John J.
    Quek, Camelia
    Wongchenko, Matthew
    Yan, Yibing
    Mann, Graham J.
    Carlino, Matteo S.
    Kefford, Richard
    Scolyer, Richard A.
    Yang, Jean
    Long, Georgina V.
    Rizos, Helen
    Menzies, Alexander M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [33] Immunohistochemical BRAF V600E Expression and Intratumor BRAF V600E Heterogeneity in Acral Melanoma: Implication in Melanoma-Specific Survival
    Ito, Takamichi
    Kaku-Ito, Yumiko
    Murata, Maho
    Furue, Kazuhisa
    Shen, Che-Hung
    Oda, Yoshinao
    Furue, Masutaka
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [34] Detection of BRAF V600E mutation by pyrosequencing
    Tan, Yi Hui
    Liu, Yanqun
    Eu, Kong Weng
    Ang, Pei Woon
    Li, Wei Qi
    Salto-Tellez, Manuel
    Iacopetta, Barry
    Soong, Richie
    PATHOLOGY, 2008, 40 (03) : 295 - 298
  • [35] Dabrafenib in advanced melanoma with BRAF V600E mutation
    Abraham, Jame
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2014, 12 (02): : 48 - 49
  • [36] Acral Lentiginous Melanomas Harbour Intratumor Heterogeneity in BRAF Exon 15, With Mutations Distinct From V600E/V600K
    Fernandes, Mariana
    Barcelos, Denise
    Comodo, Andreia Neves
    Guimaraes, Daiane Pereira
    Lopes Carapeto, Fernando Cintra
    Cardili, Leonardo
    Moraes, Lais de Sousa
    Cerutti, Janete
    Landman, Gilles
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2019, 41 (10) : 733 - 740
  • [37] Vemurafenib in Melanoma with BRAF V600E Mutation REPLY
    Chapman, Paul B.
    Hauschild, Axel
    McArthur, Grant A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (15): : 1450 - 1450
  • [38] Activation mechanisms of clinically distinct B-Raf V600E and V600K mutants
    Zhang, Mingzhen
    Maloney, Ryan
    Liu, Yonglan
    Jang, Hyunbum
    Nussinov, Ruth
    CANCER COMMUNICATIONS, 2023, 43 (03) : 405 - 408
  • [39] Investigation on crosstalk between cAMP signaling and BRAF(V600E) in melanoma
    Rodriguez, C. I.
    Maddodi, N.
    Setaluri, V.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S130 - S130
  • [40] Concordance in BRAF V600E status over time in malignant melanoma and corresponding metastases
    Nielsen, Line B.
    Dabrosin, Nina
    Sloth, Karen
    Bonnelykke-Behrndtz, Marie L.
    Steiniche, Torben
    Lade-Keller, Johanne
    HISTOPATHOLOGY, 2018, 72 (05) : 814 - 825
12345